Skip to main content
Equibles

CAPTRUST FINANCIAL ADVISORS

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1512024 RALEIGH, NC
Back to ADPT Full portfolio

Position in ADPT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
5,865
+12.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 79% Shared 0% None 21%

Common Shares in ADPT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

CAPTRUST FINANCIAL ADVISORS holds $262,357,644 across 26 Diagnostics & Research names. ADPT ranks #26 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 90,308 $45,276,818
2 WAT
Waters Corp /De/
 87,450 $32,797,248
3 DHR
Danaher Corp /De/
 170,806 $32,535,126
4 MTD
Mettler Toledo International Inc/
 25,355 $32,391,266
5 MEDP
Medpace Holdings, Inc.
 42,922 $22,731,061
6 DGX
Quest Diagnostics Inc
 95,054 $20,146,695
7 IDXX
Idexx Laboratories Inc /De
 35,025 $18,438,561
8 LH
Labcorp Holdings Inc.
 36,472 $10,212,160

All Filings in ADPT

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 — 23,459
2026-03-31 — 20,900
2025-12-31 — 20,235
2025-09-30 — 19,930
2025-06-30 — 15,762
2025-03-31 — 14,643
2024-12-31 — 13,584
2024-09-30 — 12,930
2024-06-30 — 11,313
2024-03-31 — 10,294
2023-12-31 — 11,994
2023-09-30 — 11,455
2023-06-30 — 12,195
2023-03-31 — 12,126
2022-09-30 — 12,317
2022-06-30 — 1,155
2022-03-31 — 1,528
2021-12-31 — 770
2021-09-30 — 590
2021-06-30 — 590
2021-03-31 — 1,460
2020-12-31 — 1,190
2020-09-30 — 1,196